Trials / Unknown
UnknownNCT04664283
Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography
Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography:a Prospective Multi-center Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 254 (estimated)
- Sponsor
- Liu Bin · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
OCT allows precise evaluation of intimal injury after lesion preparation and may improve the acute results and long-term outcomes after paclitaxel drug-coated balloon angioplasty. This prospective multicenter randomized controlled study aims to evaluate the long-term efficacy and safety of paclitaxel coated balloon in the treatment of native large coronary arteries by OCT guided is not inferior to drug-eluting stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DCB for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography | DCB for de Novo Lesions in Large Coronary Arteries Guided by both angiogram and Optical Coherence Tomography |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2020-12-11
- Last updated
- 2020-12-11
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04664283. Inclusion in this directory is not an endorsement.